{"id":"0f63256f-4a06-50e3-977e-3d15b3129eed","stable_key":"f8641d02-8413-5bd8-92e9-62ad49286e81:asa-structure-shows-blockage","predicate":"inhibits","statement":"The 3.4 angstrom X-ray crystal structure of prostaglandin H2 synthase isoform-1 inactivated by the potent aspirin analogue 2-bromoacetoxy-benzoic acid shows that acetylation abolishes cyclooxygenase activity by steric blockage of the active-site channel and not through a large conformational change, with two rotameric states of the acetyl-serine side chain blocking the channel to different extents, a result which may explain the dissimilar effects of aspirin on the two isoforms.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"negative","is_public":true,"mechanism_event_id":"2db14433-52fe-5db4-84ef-5ddf76188e56","mechanism_event_label":"The picture confirms it: the acetyl group simply plugs the tunnel the fatty acid has to travel down.","subject":{"id":"55fc9bed-f813-53c5-8db6-1e9cb9a8779f","slug":"acetylated-cox1","display_name":"Aspirin-acetylated cyclooxygenase-1","entity_type_key":"protein_state"},"object":{"id":"b677bbcf-dff6-53ad-b217-1274bea2e43f","slug":"cox-active-site-channel","display_name":"The hydrophobic substrate channel of the cyclooxygenase active site","entity_type_key":"protein_state"},"evidence_count":1,"mechanism_event":{"id":"2db14433-52fe-5db4-84ef-5ddf76188e56","stable_key":"f8641d02-8413-5bd8-92e9-62ad49286e81:asa-structure-shows-blockage-event","event_type":"biochemical_relationship","label":"The picture confirms it: the acetyl group simply plugs the tunnel the fatty acid has to travel down.","description":"The 3.4 angstrom X-ray crystal structure of prostaglandin H2 synthase isoform-1 inactivated by the potent aspirin analogue 2-bromoacetoxy-benzoic acid shows that acetylation abolishes cyclooxygenase activity by steric blockage of the active-site channel and not through a large conformational change, with two rotameric states of the acetyl-serine side chain blocking the channel to different extents, a result which may explain the dissimilar effects of aspirin on the two isoforms.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"a48bfecd-a348-5a1f-9cc9-9fd489127bc8","slug":"bromoacetoxy-benzoic-acid","display_name":"2-bromoacetoxy-benzoic acid, a potent aspirin analogue","entity_type_key":"chemical_species"},"role":"acetylating_analogue","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"7afd60f8-544f-59a5-809f-c985bb5637eb","slug":"steric-blockade","display_name":"Steric blockade of a substrate channel by an introduced side chain","entity_type_key":"cellular_process"},"role":"mechanism","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"7a465c55-930d-54cf-89b3-952b2c16f558","slug":"cox1-ser530","display_name":"Serine 530 of cyclooxygenase-1","entity_type_key":"protein_state"},"role":"modified_residue","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"c8a31ed4-f2ca-5d43-8352-e9935129a785","slug":"ptgs2","display_name":"Cyclooxygenase-2 (PTGS2)","entity_type_key":"protein"},"role":"contrasting_isoform","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""},{"entity":{"id":"55fc9bed-f813-53c5-8db6-1e9cb9a8779f","slug":"acetylated-cox1","display_name":"Aspirin-acetylated cyclooxygenase-1","entity_type_key":"protein_state"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":4,"notes":""},{"entity":{"id":"b677bbcf-dff6-53ad-b217-1274bea2e43f","slug":"cox-active-site-channel","display_name":"The hydrophobic substrate channel of the cyclooxygenase active site","entity_type_key":"protein_state"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":5,"notes":""}]},"contexts":[{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/aspirin-research/7552725.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"dd61431f20eb312313942bc8a89f970d5d2e33600b32abe692f20d9d5c57d7b1\", \"start_char\": 0, \"end_char\": 751, \"text_sha256\": \"dd61431f20eb312313942bc8a89f970d5d2e33600b32abe692f20d9d5c57d7b1\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"X-ray crystal structure at 3.4 angstrom of prostaglandin H2 synthase-1 inactivated by a potent aspirin analogue","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"2-bromoacetoxy-benzoic acid acetylation, with salicylic acid soaked into the structure","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Direct structural evidence rather than inference from mutants, though at modest resolution and using an analogue rather than aspirin itself.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Aspirin research collection; topical membership is not evidence of a direct clinical effect, and aspirin is recorded separately from salicylate, the metabolite it becomes.","comparator":null,"unit":null,"notes":"","entity":{"slug":"aspirin","display_name":"Aspirin / acetylsalicylic acid","entity_type_key":"drug"}},{"dimension":"organism","value_text":"Enzyme","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"The picture confirms it: the acetyl group simply plugs the tunnel the fatty acid has to travel down.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[asa-p7552725] The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthase. (1995). https://pubmed.ncbi.nlm.nih.gov/7552725/ DOI: 10.1038/nsb0895-637","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Crystallised prostaglandin H2 synthase-1","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"8ee5f62e-2b21-5b74-ad6c-b65b85516eea","evidence_kind":"source_excerpt","locator":"Lines 130-141","start_line":130,"end_line":141,"excerpt":"### asa-structure-shows-blockage\nThe 3.4 angstrom X-ray crystal structure of prostaglandin H2 synthase isoform-1 inactivated by the potent aspirin analogue 2-bromoacetoxy-benzoic acid shows that acetylation abolishes cyclooxygenase activity by steric blockage of the active-site channel and not through a large conformational change, with two rotameric states of the acetyl-serine side chain blocking the channel to different extents, a result which may explain the dissimilar effects of aspirin on the two isoforms.\nCondition category: normal\nnutrient_topic: Aspirin research collection; topical membership is not evidence of a direct clinical effect, and aspirin is recorded separately from salicylate, the metabolite it becomes.\nplain_language: The picture confirms it: the acetyl group simply plugs the tunnel the fatty acid has to travel down.\norganism: Enzyme\ntissue_or_cell_type: Crystallised prostaglandin H2 synthase-1\nexperimental_model: X-ray crystal structure at 3.4 angstrom of prostaglandin H2 synthase-1 inactivated by a potent aspirin analogue\nlimitations: Direct structural evidence rather than inference from mutants, though at modest resolution and using an analogue rather than aspirin itself.\nexposure: 2-bromoacetoxy-benzoic acid acetylation, with salicylic acid soaked into the structure\nevidence_span: {\"source_cache\": \"artifacts/aspirin-research/7552725.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"dd61431f20eb312313942bc8a89f970d5d2e33600b32abe692f20d9d5c57d7b1\", \"start_char\": 0, \"end_char\": 751, \"text_sha256\": \"dd61431f20eb312313942bc8a89f970d5d2e33600b32abe692f20d9d5c57d7b1\"}\n[asa-p7552725] The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthase. (1995). https://pubmed.ncbi.nlm.nih.gov/7552725/ DOI: 10.1038/nsb0895-637","model_system":"X-ray crystal structure at 3.4 angstrom of prostaglandin H2 synthase-1 inactivated by a potent aspirin analogue","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [asa-p7552725] The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthase. (1995). https://pubmed.ncbi.nlm.nih.gov/7552725/ DOI: 10.1038/nsb0895-637","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"712cf519-cd27-5a8b-9e2f-961a98d7a27e","stable_key":"import-f8641d02-8413-5bd8-92e9-62ad49286e81","title":"Aspirin: the serine it acetylates, the enzyme that acetylation creates, the dose that separates platelet from vessel wall, and the metabolite that is a different drug (2026-09-22)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"93dd4343051c131e40d4fc3c95a978cd65478c13dcdb3f2d42507c49b09cb647","revision_id":"694e8ee7-49ca-5e6c-b58b-8ba8f82c2ad8","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}